The Translational Research Working Group developmental pathway for anticancer agents (drugs or biologics).
The Translational Research Working Group (TRWG) was created as a national initiative to evaluate the current status of the National Cancer Institute's investment in translational research and envision its future. The TRWG conceptualized translational research as a set of six developmental processes or pathways focused on various clinical goals. One of those pathways describes the development of agents-both small molecules and biologics-for the treatment and prevention of cancer. The Agents Developmental Pathway was conceived not as a comprehensive description of the corresponding real-world processes, but rather as a tool designed to facilitate movement of an agent through the translational process to the point where it can begin definitive clinical testing. This article presents the Agents Developmental Pathway and discusses key challenges associated with the processes described.
Schilsky
Richard L
RL
University of Chicago, Chicago, Illinois, USA.
Gordon
Gary
G
Gilmer
Tona M
TM
Courtneidge
Sara A
SA
Matrisian
Lynn M
LM
Grad
Oren
O
Nelson
William G
WG
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001688:Biological Products / Q000627:therapeutic use*; D015415:Biomarkers / Q000032:analysis; D019496:Cancer Vaccines / Q000627:therapeutic use*; D016503:Drug Delivery Systems; D015195:Drug Design; D006801:Humans; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000628:therapy*; D016730:Program Development; D012985:Software Design; D014481:United States
D000970:Antineoplastic Agents; D001688:Biological Products; D015415:Biomarkers; D019496:Cancer Vaccines
N Engl J Med. 2005 Jul 14;353(2):123-32
16014882
Proc Natl Acad Sci U S A. 1990 Sep;87(17):6649-53
2204061
Nature. 2006 May 25;441(7092):451-6
16724057
JAMA. 2003 Oct 22;290(16):2149-58
14570950
Nature. 1973 Jun 1;243(5405):290-3
4126434
N Engl J Med. 2002 Feb 28;346(9):645-52
11870241
Science. 1990 Feb 16;247(4944):824-30
2406902
Cancer Res. 2002 Sep 1;62(17):4996-5000
12208752
J Clin Oncol. 2003 Jun 15;21(12):2237-46
12748244
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13306-11
15329413
Clin Chem. 2000 May;46(5):673-83
10794750
Science. 1996 Nov 1;274(5288):784-7
8864119
J Clin Oncol. 2005 Sep 1;23(25):5892-9
16043829
J Clin Oncol. 2007 Aug 1;25(22):3230-7
17664471
Cell. 1994 Sep 9;78(5):773-85
8087845
N Engl J Med. 2004 May 20;350(21):2129-39
15118073
N Engl J Med. 2001 Apr 5;344(14):1031-7
11287972
J Clin Oncol. 2005 Apr 10;23(11):2556-68
15767641
Science. 1990 Mar 2;247(4946):1079-82
2408149
Science. 1996 Nov 1;274(5288):782-4
8864118
J Clin Oncol. 2004 Apr 1;22(7):1201-8
14993230
Clin Cancer Res. 2008 Sep 15;14(18):5672-7
18794074
Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):3954-64
15217925
Cancer Res. 2001 Apr 1;61(7):3071-6
11306489
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15671-6
9861028
Clin Cancer Res. 2008 Sep 15;14(18):5664-71
18612047
PLoS Med. 2005 Jan;2(1):e17
15696205
Science. 2004 Jun 4;304(5676):1497-500
15118125
Bioorg Med Chem Lett. 1998 Feb 17;8(4):333-8
9871680
Cancer Res. 1999 Jun 1;59(11):2615-22
10363983
Nature. 1990 Mar 15;344(6263):251-3
2179728
J Natl Cancer Inst. 2000 Feb 2;92(3):205-16
10655437
Annu Rev Med. 1999;50:57-74
10073263
Science. 1996 Nov 1;274(5288):787-9
8864120
Curr Opin Chem Biol. 2002 Aug;6(4):493-500
12133726
N Engl J Med. 2004 Jul 22;351(4):337-45
15269313